Grifols (GIKLY) Profit After Tax (2010 - 2020)
Grifols (GIKLY) posted Profit After Tax of $224.7 million for Q1 2020, down 54.53% quarter-over-quarter from $494.1 million in Q4 2019, and up 72.98% year-on-year from $129.9 million in Q2 2019.
Grifols (GIKLY) Profit After Tax (2010 - 2020) Analysis & Trends
Grifols (GIKLY) has reported Profit After Tax for 10 consecutive years, with $224.7 million the latest figure, recorded in Q1 2020.
- Profit After Tax for Q1 2020 came in at $224.7 million, up 72.98% year-over-year; the trailing twelve-month figure through Mar 2020 was $1.4 billion (up 31.95% YoY), and the FY2025 annual result was $582.0 million, up 9415.33% from the prior year.
- Profit After Tax was $224.7 million for Q1 2020 at Grifols, down from $494.1 million in the prior quarter.
- Over five years, Profit After Tax peaked at $532.4 million in Q4 2018 and troughed at $129.9 million in Q1 2019.
- Average Profit After Tax over 5 years is $263.1 million, with a median of $175.5 million recorded in 2018.
- Year-over-year, Profit After Tax sank 80.16% in 2016 and jumped 237.84% in 2017.
- Over 5 years, Profit After Tax stood at $150.1 million in 2016, then surged by 237.84% to $507.2 million in 2017, then climbed by 4.99% to $532.4 million in 2018, then declined by 7.2% to $494.1 million in 2019, then tumbled by 54.53% to $224.7 million in 2020.
- Per Business Quant data, the three most recent Profit After Tax figures were $224.7 million in Q1 2020, $494.1 million in Q4 2019, and $129.9 million in Q1 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 7.40 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 5.24 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 697.00 Mn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 3.08 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | -4.24 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 1.82 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 2.02 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 2.71 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Grifols | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 224.70 Mn |
| Dec 31, 2019 | 494.12 Mn |
| Mar 31, 2019 | 129.89 Mn |
| Dec 31, 2018 | 532.45 Mn |
| Sep 30, 2018 | 546.22 Mn |
| Jun 30, 2018 | 208.87 Mn |
| Mar 31, 2018 | 175.52 Mn |
| Dec 31, 2017 | 507.16 Mn |
| Jun 30, 2017 | 157.93 Mn |
| Mar 31, 2017 | 142.48 Mn |
| Dec 31, 2016 | 150.12 Mn |
| Sep 30, 2016 | 157.85 Mn |
| Jun 30, 2016 | 157.35 Mn |
| Mar 31, 2016 | 381.34 Mn |
| Dec 31, 2015 | 756.59 Mn |
| Sep 30, 2015 | 155.63 Mn |
| Jun 30, 2015 | 146.72 Mn |
| Mar 31, 2015 | 144.42 Mn |
| Dec 31, 2014 | 737.00 Mn |
| Sep 30, 2014 | 150.66 Mn |